References
- Fleischer AB Jr, Ford PG. How to prevent side effects of topical corticosteroids. Skin & Aging 1998 February: 54–65
- Prawer SE, Katz HI. Guidelines for using superpotent topical steroids. Am Fam Physician 1990; 41(5): 1531–8
- Brodkin RH, Janniger CK. The artful use of topical steroids. Cutis 1998; 61(3): 125–6
- Wells K, Brodeil RT. Topical corticosteroid “addiction”: a cause of perioral dermatitis. Postgrad Med 1993; 93(5): 225–30
- Booth BA, Tan EM, Oikarinen A, et al. Steroid-induced dermal atrophy: effects of glucocorticosteroids on collagen metabolism in human skin fibroblast cultures. Int J Dermatol 1982; 21(6): 333–7
- Fisher DA. Adverse effects of topical corticosteroid use. West J Med 1995; 162(2): 123–6
- Morman MR. Possible side effects of topical steroids. Am Fam Physician 1981; 23(2): 171–4
- Leyden JJ, Thew M, Kligman AM. Steroid rosacea. Arch Dermatol 1974; 110(4): 619–22
- Korting HC, Kerscher MJ, Schäfer Korting M. Topical glucocorticoids with improved benefit/risk ratio: do they exist? J Am Acad Dermatol 1992; 27(1): 87–92
- Wilkinson DS, Kirton V, Wilkinson JD. Perioral dermatitis: a 12-year review. Br J Dermatol 1979; 101(3): 245–57
- Go MJ, Wuite J. Comparative study of triamcinolone acetonide and hydrocortisone 17-butyrate in rosacea with special regard to the rebound phenomenon. Dermatologica 1976; 152(Suppl 1): 239–46
- Millikan LE. Topical corticosteroid therapy. Mo Med 1981; 78(5): 237–42
- Mellette JR Jr, Aeling JL, Nuss DD. Perioral dermatitis. J Assoc Milit Dermatol 1983; 9(1): 3–8
- Sneddon I. Adverse effect of topical fluorinated corticosteroids in rosacea. Br Med J 1969; 1(645): 671–3
- Sneddon IB. The treatment of steroid-induced rosacea and perioral dermatitis. Dermatologica 1976; 152(Suppl 1): 231–7
- Bikowski JB. Topical therapy for perioral dermatitis. Cutis 1983; 31(6): 678–82